Published in Neurobiol Aging on September 24, 2008
Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 3.31
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology (2011) 2.08
Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology (2011) 1.83
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging (2010) 1.70
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement (2011) 1.59
Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes (2012) 1.49
Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin (2013) 1.49
Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage (2010) 1.45
Surface-based TBM boosts power to detect disease effects on the brain: an N=804 ADNI study. Neuroimage (2011) 1.41
Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease. Alzheimer Dis Assoc Disord (2012) 1.40
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp (2010) 1.40
Surface fluid registration of conformal representation: application to detect disease burden and genetic influence on hippocampus. Neuroimage (2013) 1.33
Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease. Neurobiol Dis (2011) 1.31
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord (2010) 1.31
In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI. J Alzheimers Dis (2012) 1.30
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging (2010) 1.22
Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles. Brain (2013) 1.20
Applying tensor-based morphometry to parametric surfaces can improve MRI-based disease diagnosis. Neuroimage (2013) 1.17
Hippocampal CA1 apical neuropil atrophy and memory performance in Alzheimer's disease. Neuroimage (2012) 1.11
Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease. Neuroimage Clin (2014) 1.05
Striatal hypertrophy and its cognitive effects in new-onset benign epilepsy with centrotemporal spikes. Epilepsia (2012) 1.03
The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease. Neuroimage Clin (2013) 1.03
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging (2012) 1.02
Hippocampal subfield volumes: age, vascular risk, and correlation with associative memory. Front Aging Neurosci (2011) 1.01
Hippocampal volumetry: Normative data in the Indian population. Ann Indian Acad Neurol (2014) 0.97
Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry. Neuroimage (2014) 0.97
Quantitative structural MRI for early detection of Alzheimer's disease. Expert Rev Neurother (2010) 0.96
Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study. Hum Brain Mapp (2014) 0.96
Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv Pharmacol (2012) 0.94
Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 0.93
Energetic interventions for healthspan and resiliency with aging. Exp Gerontol (2016) 0.92
Caudate atrophy and impaired frontostriatal connections are linked to executive dysfunction in temporal lobe epilepsy. Epilepsy Behav (2011) 0.92
Mnemonic strategy training improves memory for object location associations in both healthy elderly and patients with amnestic mild cognitive impairment: a randomized, single-blind study. Neuropsychology (2012) 0.91
Measuring longitudinal change in the hippocampal formation from in vivo high-resolution T2-weighted MRI. Neuroimage (2012) 0.91
Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults. J Alzheimers Dis (2015) 0.90
Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease. Hum Brain Mapp (2015) 0.90
Why looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis. Front Cell Neurosci (2014) 0.89
Hippocampal shape analysis in Alzheimer's disease and frontotemporal lobar degeneration subtypes. J Alzheimers Dis (2012) 0.89
Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology (2015) 0.88
Evaluating Alzheimer's disease progression using rate of regional hippocampal atrophy. PLoS One (2013) 0.87
White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. Neurobiol Aging (2014) 0.87
Effects of aging and Alzheimer's disease along the longitudinal axis of the hippocampus. J Alzheimers Dis (2013) 0.87
Interactive effects of chronic cigarette smoking and age on hippocampal volumes. Drug Alcohol Depend (2013) 0.86
Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture. Aging Cell (2010) 0.86
Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals. BMC Med (2012) 0.85
Recent advances in imaging Alzheimer's disease. J Alzheimers Dis (2013) 0.85
A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Neuropsychologia (2015) 0.85
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease. Neuroimage Clin (2014) 0.83
Structural brain alterations before mild cognitive impairment in ADNI: validation of volume loss in a predefined antero-temporal region. J Alzheimers Dis (2012) 0.83
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain (2015) 0.83
Alzheimer disease: 'generation next' in Alzheimer disease genetic studies. Nat Rev Neurol (2013) 0.82
The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp (2015) 0.81
Brain region's relative proximity as marker for Alzheimer's disease based on structural MRI. BMC Med Imaging (2014) 0.81
Structural imaging in early pre-states of dementia. Biochim Biophys Acta (2011) 0.81
Where did I put that? Patients with amnestic mild cognitive impairment demonstrate widespread reductions in activity during the encoding of ecologically relevant object-location associations. Neuropsychologia (2011) 0.81
The Combined Effect of Neuropsychological and Neuropathological Deficits on Instrumental Activities of Daily Living in Older Adults: a Systematic Review. Neuropsychol Rev (2016) 0.80
Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol. Alzheimers Dement (2015) 0.80
Hippocampal complex atrophy in poststroke and mild cognitive impairment. J Cereb Blood Flow Metab (2015) 0.79
Expression of Nampt in hippocampal and cortical excitatory neurons is critical for cognitive function. J Neurosci (2014) 0.79
Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease. Aust N Z J Psychiatry (2012) 0.79
Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials. Neurotherapeutics (2016) 0.79
Author's Reply: Regarding issues with article on hippocampal volumetry. Ann Indian Acad Neurol (2015) 0.79
Brain imaging of neurovascular dysfunction in Alzheimer's disease. Acta Neuropathol (2016) 0.79
Parahippocampal white matter volume predicts Alzheimer's disease risk in cognitively normal old adults. Neurobiol Aging (2014) 0.78
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. J Prev Alzheimers Dis (2014) 0.78
Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of Alzheimer's disease. Diagn Pathol (2011) 0.78
mNos2 deletion and human NOS2 replacement in Alzheimer disease models. J Neuropathol Exp Neurol (2014) 0.78
Abnormal Resting-State Functional Connectivity Strength in Mild Cognitive Impairment and Its Conversion to Alzheimer's Disease. Neural Plast (2015) 0.78
Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons. Brain Struct Funct (2014) 0.77
Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies. Dement Geriatr Cogn Disord (2012) 0.77
The Primacy Effect in Amnestic Mild Cognitive Impairment: Associations with Hippocampal Functional Connectivity. Front Aging Neurosci (2016) 0.77
3D tract-specific local and global analysis of white matter integrity in Alzheimer's disease. Hum Brain Mapp (2016) 0.76
Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects. J Gerontol A Biol Sci Med Sci (2016) 0.75
Dance Experience and Associations with Cortical Gray Matter Thickness in the Aging Population. Dement Geriatr Cogn Dis Extra (2016) 0.75
Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative. J Alzheimers Dis (2010) 0.75
Morphological and Microstructural Changes of the Hippocampus in Early MCI: A Study Utilizing the Alzheimer's Disease Neuroimaging Initiative Database. J Clin Neurol (2017) 0.75
Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease Patients. Front Aging Neurosci (2017) 0.75
Hippocampal atrophy varies by neuropsychologically defined MCI among men in their 50s. Am J Geriatr Psychiatry (2014) 0.75
The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Alzheimers Dement (Amst) (2015) 0.75
Functional joint model for longitudinal and time-to-event data: an application to Alzheimer's disease. Stat Med (2017) 0.75
Dynamic predictions in Bayesian functional joint models for longitudinal and time-to-event data: An application to Alzheimer's disease. Stat Methods Med Res (2017) 0.75
Cognitive dysfunction in major depression and Alzheimer's disease is associated with hippocampal-prefrontal cortex dysconnectivity. Neuropsychiatr Dis Treat (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol (2003) 14.87
Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol (1999) 10.45
Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol (2006) 6.20
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology (2004) 5.86
Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging (2004) 5.68
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage (2004) 5.07
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol (1990) 3.96
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A (2001) 3.86
Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science (2003) 3.67
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience (2000) 3.40
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging (2005) 3.32
Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage (2005) 3.21
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol (2006) 3.11
Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage (2003) 2.77
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain (2006) 2.73
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage (2005) 2.51
Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T. Neurobiol Aging (2006) 2.48
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol (1993) 2.44
Global Deterioration Scale (GDS). Psychopharmacol Bull (1988) 2.14
An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord (2006) 2.08
Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology (2003) 2.00
Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging (2007) 1.90
Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry (2006) 1.85
Detection, visualization and animation of abnormal anatomic structure with a deformable probabilistic brain atlas based on random vector field transformations. Med Image Anal (1997) 1.68
Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.67
Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch Neurol (2006) 1.65
The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies. Neurobiol Aging (1997) 1.57
In vivo neuropathology of the hippocampal formation in AD: a radial mapping MR-based study. Neuroimage (2006) 1.49
MRI-based hippocampal volumetrics: data acquisition, normal ranges, and optimal protocol. Magn Reson Imaging (1995) 1.26
Brain mapping as a tool to study neurodegeneration. Neurotherapeutics (2007) 1.24
A preliminary report on a new memory scale. Percept Mot Skills (1968) 1.19
Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Res (1998) 1.12
A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. J Geriatr Psychiatry Neurol (1993) 1.05
Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia (1995) 0.97
Diagnostic criteria for Alzheimer's disease. Neurobiol Aging (1997) 0.94
Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A (2004) 17.86
Alzheimer's disease. Lancet (2006) 9.15
Mapping cortical change across the human life span. Nat Neurosci (2003) 8.98
Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci (2004) 7.30
PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med (2006) 6.02
Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage (2007) 5.86
Mapping brain asymmetry. Nat Rev Neurosci (2003) 4.99
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science (2003) 3.67
Mapping brain maturation. Trends Neurosci (2006) 3.60
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40
Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol (2003) 3.26
Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. Cereb Cortex (2006) 3.23
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol (2006) 3.11
Brain structure and obesity. Hum Brain Mapp (2010) 3.04
Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging (2003) 2.96
Genus zero surface conformal mapping and its application to brain surface mapping. IEEE Trans Med Imaging (2004) 2.93
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
Mapping changes in the human cortex throughout the span of life. Neuroscientist (2004) 2.86
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain (2006) 2.73
Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet (2003) 2.71
3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage (2006) 2.69
Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex (2004) 2.66
The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain (2007) 2.53
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage (2005) 2.51
Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry (2005) 2.48
Genetics of brain fiber architecture and intellectual performance. J Neurosci (2009) 2.42
Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci U S A (2007) 2.41
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
Towards multimodal atlases of the human brain. Nat Rev Neurosci (2006) 2.37
Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Hum Brain Mapp (2007) 2.36
Statistical properties of Jacobian maps and the realization of unbiased large-deformation nonlinear image registration. IEEE Trans Med Imaging (2007) 2.33
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. Proc Natl Acad Sci U S A (2010) 2.32
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Senescence rates are determined by ranking on the fast-slow life-history continuum. Ecol Lett (2008) 2.30
Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage (2009) 2.28
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Robust brain extraction across datasets and comparison with publicly available methods. IEEE Trans Med Imaging (2011) 2.22
Neurobiology of intelligence: science and ethics. Nat Rev Neurosci (2004) 2.22
Dynamic mapping of normal human hippocampal development. Hippocampus (2006) 2.21
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med (2006) 2.17
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging (2009) 2.15
Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging (2010) 2.13
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12
Surface-constrained volumetric brain registration using harmonic mappings. IEEE Trans Med Imaging (2007) 2.11
Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci U S A (2002) 2.10
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging (2008) 2.04
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03
Genetics of brain structure and intelligence. Annu Rev Neurosci (2005) 2.02
Extracting and Representing the Cortical Sulci. IEEE Comput Graph Appl (1999) 2.01
Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology (2003) 2.00
A Hough transform global probabilistic approach to multiple-subject diffusion MRI tractography. Med Image Anal (2011) 1.98
Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res (2009) 1.98
Genetics of white matter development: a DTI study of 705 twins and their siblings aged 12 to 29. Neuroimage (2010) 1.96
Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A (2003) 1.95
Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage (2010) 1.94
Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res (2007) 1.93
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry (2008) 1.93
Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage (2007) 1.93
Lifespan trajectory of myelin integrity and maximum motor speed. Neurobiol Aging (2008) 1.92
Diffusion imaging, white matter, and psychopathology. Annu Rev Clin Psychol (2011) 1.91
A genome-wide association study identifies five loci influencing facial morphology in Europeans. PLoS Genet (2012) 1.91
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging (2007) 1.90
Relationships between IQ and regional cortical gray matter thickness in healthy adults. Cereb Cortex (2006) 1.87
Regional specificity of hippocampal volume reductions in first-episode schizophrenia. Neuroimage (2004) 1.87
Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. Cereb Cortex (2006) 1.87
Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement (2007) 1.82
Comparison of AdaBoost and support vector machines for detecting Alzheimer's disease through automated hippocampal segmentation. IEEE Trans Med Imaging (2009) 1.80
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: a pilot project of the ENIGMA-DTI working group. Neuroimage (2013) 1.78
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage (2012) 1.76
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol (2013) 1.75
Mapping corpus callosum deficits in autism: an index of aberrant cortical connectivity. Biol Psychiatry (2006) 1.75
Regional brain shape abnormalities persist into adolescence after heavy prenatal alcohol exposure. Cereb Cortex (2002) 1.74
Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults. J Neurosci (2011) 1.74
Mapping sulcal pattern asymmetry and local cortical surface gray matter distribution in vivo: maturation in perisylvian cortices. Cereb Cortex (2002) 1.73
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging (2010) 1.70